Autologous Micrograft Technology and Finasteride for the Management of Androgenic Alopecia: A Systematic Review and Meta-Analysis of Efficacy and Safety

This systematic review and meta-analysis compared the efficacy of autologous micrograft technology (AMT) and finasteride in managing androgenetic alopecia (AGA). The study found that AMT may be superior to finasteride (≥1mg/day) for promoting hair growth. Both treatments showed small effect sizes in improving hair count, but AMT demonstrated a medium effect size in the percentage of patients benefitting from the treatment, compared to a small effect size for finasteride. The findings suggest that AMT is an effective method for promoting hair growth in AGA patients and may be more effective than finasteride.